 |
|
|
|
|
|
|
|
|
|
|
 |
|
|||||||||
 |
 |
 |
 |
 |
 |
 |
 |
|
||
 |
 |
 |
|
|||||||
 |
|
|||||||||
 |
|
|||||||||
Alert Number 100
Date: June 20, 2024
The latest issue of the journal "Leukemia" has an important article that reports unexpectedly high hematological toxicity, serious infections and even death, following therapy with Campath + G-CSF. The story just goes to show that it is no slam dunk predicting the results one will get with drug combinations. That is why we need the research and the clinical trials. We are grateful to the Ohio State research team for their rapid publication of these disturbing results. Good news is sexy and everyone likes a winner. But rapid publication of unexpected problems and toxicity saves lives by giving us and our doctors a very important heads-up. You can read the story in Campath plus G-CSF
Be well,
Chaya
_____
NOTICE: This page from the Topics Alert archive was originally emailed to subscribers of Topics Alert, a free service of CLL Topics Inc. If you are not a subscriber and you wish to receive email Alerts, please register at the Topics Alert subscription page. The content of this page is intended for information only and it is NOT meant to be medical advice. Please be sure to consult and follow the advice of your doctors on all medical matters.
———
Disclaimer: The content of this website is intended for information only and is NOT meant to be medical advice. Please be sure to consult and follow the advice of your doctors on all medical matters.
Copyright Notice:
Copyright © 2024-2007 CLL Topics, Inc. All Rights Reserved.
All materials contained on this site are protected by United States copyright law and may not be reproduced, distributed, transmitted, displayed, published or broadcast without the prior written permission of CLL Topics, Inc. You may not alter or remove any trademark, copyright or other notice from copies of the content.
However, you may download and print material from CLLTopics.org exclusively for your personal, noncommercial use.
———
